Web1 giu 2024 · LBA5 Background: Osimertinib is a 3rd-generation, CNS-active, EGFR-TKI with superior efficacy to comparator EGFR-TKI (gefitinib/erlotinib) in treatment-naïve EGFRm advanced NSCLC. Approx. 30% of pts with NSCLC present with early stage (I–IIIA) disease; surgery is the primary treatment. Adjuvant chemotherapy is standard of care in pts with … WebPhysicians from institutions that participated in the JCOG0707 retrospectively assessed the medical records of each patient. Results: This study enrolled 5006 patients, 85% of those …
Multicenter observational cohort study of post-operative …
WebThe results of this cohort study will be useful for external validity of the results of clinical trial such as JCOG0707. Keywords: early stage; non-small-cell lung cancer; observational cohort study; post-operative adjuvant chemotherapy; randomized Phase III study. © The Author 2015. Published by Oxford University Press. http://www.jcog.jp/document/0707.pdf ecology of central european forests
Multicenter observational cohort study of post-operative
Web17 nov 2024 · The Japan Clinical Oncology Group (JCOG) initiated a randomized Phase III trial (JCOG0707, the UMIN Clinical Trials Registry as UMIN000001494) comparing the … http://www.jcog.jp/ Web1 dic 2024 · The JCOG Data Center performed this randomization using the minimization method to balance for institution, pathologic stage (IA or IB), histology … ecology of a cracker childhood summary